SMTL ID : 3ddw.1

Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK055

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.90 Å
Oligo State
homo-dimer
Ligands
2 x NBG: SUGAR (1-N-ACETYL-BETA-D-GLUCOSAMINE)(Non-covalent)
2 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)
2 x CFF: CAFFEINE(Non-covalent)
2 x 055: (2S)-{[(3-{[(2-CHLORO-6-METHYLPHENYL)CARBAMOYL]AMINO}NAPHTHALEN-2-YL)CARBONYL]AMINO}(PHENYL)ETHANOIC ACID(Non-covalent)
2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
2 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Thomson, S.A. et al., Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy. Bioorg.Med.Chem.Lett. (2009)
Release Date
2009-01-27
Peptides
Glycogen phosphorylase, liver form: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Glycogen phosphorylase, liver form

Related Entries With Identical Sequence

3dd1.1 | 3dds.1